The market for sucralfate is anticipated to rise as research and development efforts to find new medicines employing sucralfate increase. For instance, sucralfate and honey are used to treat esophageal damage in infants and children, according to a report published in April 2018 by the American Broncho Esophagological Association. Consumption of button batteries (BB), small disc-shaped batteries frequently found in toys, is linked to esophageal harm in newborns and kids. The combination of sucralfate and honey can reduce the effects of button batteries and provide symptomatic relief for esophageal injuries. Due to the growing number of clinical studies, North America is predicted to hold the leading position in the sucralfate market. As an illustration, the University of Texas is carrying out a clinical phase II study on sucralfate to enhance oral intake in kids with infected oral ulcers. By June 2019, the study should be finished.
According to the Coherent Market Insights, The size of the world market for Sucralfate was estimated at USD 253.11 million in 2022 and is anticipated to grow at a CAGR of 4.05% over the course of the forecast period, reaching USD 321.11 million by 2028.
Prominent Players in the Sucralfate Industry:
1. SRL Pharma
The company was founded in 1975 and has its main office in Germany. SRLPharma serves the pharmaceutical, biotechnology, and academic sectors with sensory and consumer science services on a global scale. The business offers services in the fields of gypsum, cosmetics, and pharmaceuticals.
2. Nitika Chemicals
The business was started in 1991 and is based in Nagpur. Providing a variety of pharmaceutical excipients, antacid active ingredients, and mineral salts, Nitika Pharma is a top excipients company. The company manufactures excipients, refined mineral salt, granulates, pelletization, and other chemicals.
3. Teva Pharmaceutical Industries Ltd.
The corporation, founded in 1901, has its headquarters in Tel Aviv, Israel. The company has certain supplemental business interests in active pharmaceutical ingredients and, to a lesser extent, proprietary medications, despite the fact that generic drugs are its major area of expertise. The Science Based ambitions programme (SBTi) estimates that on January 19, 2023, Teva's ambitious climate ambitions will have been independently verified. The federal opioids deal will move forward, Teva stated on January 9th, 2023, after getting broad backing from the states.
4. Lisapharma S.p.A
The company was founded in 1925 and has its headquarters in Italy. A pharmaceutical business called Lisapharma produces sterile injectable medications as its area of expertise. A biopharmaceutical company named Lisapharma has been supplying speciality medications to markets all around the world.
5. Aptalis Pharma US, Inc.,
The firm was started in 2011 and has its main office in Lawrenceville, New Jersey. Leading specialised pharmaceutical provider Aptalis Pharma Inc. offers cutting-edge, potent treatments for unmet medical needs. Manufacturing, producing, or processing pharmaceuticals into pharmaceutical formulations for human or veterinary use is a part of the company's line of business.
6. Abcam Plc,
The company was established in 1998 and is based in Cambridge, United Kingdom. Protein research instruments are made, distributed, and sold by Abcam. The business Abcam plc is in the biotechnology industry. The business provides therapeutic, investigative, and diagnostic services. As it was announced in January 2020, Abcam had successfully acquired Expedeon's Proteomics and Immunology division, which also comprised Innova and TGR Biosciences.
7. Uniprix Group
The company was founded in 1977 and has its main office in Montreal, Canada. The company sells items for wound and foot care in addition to health and beauty care, baby care, cosmetics, over-the-counter drugs, natural health, hair care, shampoos, conditioners, and sun protection.
*Definition: The generic version of the brand-name medication Carafate is called sucralfate. It is a prescription drug used to treat peptic ulcer disease, upper gastrointestinal tract ulcers, and to stop ulcers from coming back.
